Yaowei Lv

Yaowei Lv

Auto-generated profile, based on publicly available information

Yaowei Lv

National Center for Orthopaedics, Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
YLYaowei Lv
Yaowei Lv
XYXiangyun Yao
Xiangyun Yao
XLXiao Li
Xiao Li
YOYuanming Ouyang
Yuanming Ouyang
CFCunyi Fan
Cunyi Fan
YQYun Qian
Yun Qian
JOURNAL/nrgr/04.03/01300535-202403000-00034/inline-graphic1/v/2023-09-27T141015Z/r/image-tiff Diabetic peripheral neuropathy is a common complication of diabetes mellitus. Elucidating the pathophysiological metabolic mechanism impels the generation of ideal therapies. However, existing limited treatments for diabetic peripheral neuropathy expose the urgent need for cell metabolism research. Given the lack of comprehensive understanding of energy metabolism changes and related signaling pathways in diabetic peripheral neuropathy, it is essential to explore energy changes and metabolic changes in diabetic peripheral neuropathy to develop suitable treatment methods. This review summarizes the pathophysiological mechanism of diabetic peripheral neuropathy from the perspective of cellular metabolism and the specific interventions for different metabolic pathways to develop effective treatment methods. Various metabolic mechanisms (e.g., polyol, hexosamine, protein kinase C pathway) are associated with diabetic peripheral neuropathy, and researchers are looking for more effective treatments through these pathways.

2 May 2024
Verified
Preprint
Open access
PDF file
YLYaowei Lv
Yaowei Lv
XYXiangyun Yao
Xiangyun Yao
LZLei Zhan
Lei Zhan
JSJinye Shi
Jinye Shi
XWXiangyang Wang
Xiangyang Wang
YOYuanming Ouyang
Yuanming Ouyang
Perturbations of the immune homeostasis following peripheral nerve injury (PNI) disturbs growth microenvironment that delays nerve repair. Although extensive efforts have been made to stimulate nerve regeneration, their efficacy is limited by energy deficiency and persistent and overactive inflammation. It is not yet clear how exogenous implantable neural electrical stimulation system regulates immune homeostasis and promotes peripheral nerve regeneration. Here reports a self-powered immunoactive scaffold based on piezoelectric and electroconductive materials. Such in situ electrical stimulation technique regulates lasting and high-level inflammatory cytokines infiltrated in injured nerve tissue, modulates aberrant neutrophil activities and promotes fast revascularization. By benefiting immune balance and angiogenesis, this electroactive scaffold averts growth-suppression following PNI and robustly facilitates neural regeneration. Therefore, this piezoelectric model represents an effective tool for PNI immunotherapy.

18 December 2025 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
XWXinyu Wang
Xinyu Wang
Wencai LiuWencai Liu
Wencai Liu
YTYuanhao Tong
Yuanhao Tong
YLYaowei Lv
Yaowei Lv
LHLimin Han
Limin Han
YOYuanming Ouyang
Yuanming Ouyang
Background: Elbow stiffness is a condition that causes mobility dysfunction and severe suffering in patients. Patients with posttraumatic elbow stiffness who undergo open elbow arthrolysis are at risk for poor postoperative flexion-extension outcome, which leads us to suspect that these patients possess a unique “elbow stiffness predisposition.” Purpose: To develop an innovative predictive model that combines clinical and laboratory indicators to forecast poor flexion-extension outcomes after open elbow arthrolysis, thereby interpreting the “elbow stiffness predisposition.” Study Design: Cohort study; Level of evidence, 3. Methods: Patients who underwent open elbow arthrolysis between 2019 and 2022 were selected for model training and validation (n = 254), while those who underwent open elbow arthrolysis between 2016 and 2017 served as a test set (n = 35). The study assessed 19 clinical features and 58 laboratory parameters. A comparative analysis of several machine learning models—logistic regression, Naive Bayes, decision trees, random forest, gradient boosting, and XGBoost—was performed to identify the most effective approach. SHapley Additive exPlanations (SHAP) were employed to prioritize the key factors. Results: Using univariate analysis and the least absolute shrinkage and selection operator (LASSO) regression, 14 key variables were selected for inclusion in the model. The XGBoost model demonstrated superior performance, reaching an area under the curve of 0.909 on the test dataset. The most important indicator identified by LASSO was alkaline phosphatase. Indicators ranked by SHAP were lipoprotein(a), alkaline phosphatase, visual analog scale score, serum calcium, basophil count, serum sodium, previous arthrolysis, alanine aminotransferase, blood glucose, preoperative elbow range of motion, Cystatin C, uric acid, tobacco use, and serum cholinesterase. Conclusion: We have successfully developed a machine learning model using 14 key indicators to predict poor flexion-extension outcomes, which preliminarily explains the “elbow stiffness predisposition.”